by Extivita | May 1, 2016 | Diabetic Foot Ulcers
Abstract: The intralesional injection of recombinant human epidermal growth factor (EGF-IL), a new therapy, has been claimed to prevent major amputations in advanced diabetic foot lesions. In this study, the efficacy of EGF-IL on advanced diabetic foot ulcers (DFU)...
by Extivita | May 1, 2016 | Diabetic Foot Ulcers
Abstract: The intralesional injection of recombinant human epidermal growth factor (EGF-IL), a new therapy, has been claimed to prevent major amputations in advanced diabetic foot lesions. In this study, the efficacy of EGF-IL on advanced diabetic foot ulcers (DFU)...
by Extivita | Oct 21, 2014 | Diabetic Foot Ulcers
Abstract: Uzun, Mutluoglu, Yildiz, , , , , , (). Appropriate analysis and presentation of data in wound healing studies: should we publish individual patient data? Wound repair and regeneration : official publication of the Wound Healing Society [and] the European...
by Extivita | Mar 24, 2011 | Diabetic Foot Ulcers
Abstract: This study investigated the molecular changes of extracorporeal shockwave therapy (ESWT) and hyperbaric oxygen therapy (HBOT) in chronic diabetic foot ulcers. A cohort study consisted of 39 patients (44 ulcers) in the ESWT group and 38 patients (40 ulcers)...
